Prebiotics After Autologous Stem Cell Transplant
A Pilot, Randomized, Double-blind, Placebo-controlled Study Using Prebiotics to Improve Gut Microbiome Diversity After Autologous Stem Cell Transplantation in Multiple Myeloma and Lymphoma: The PRIMAL Trial
More Information
- Trial Status
- Accepting patients
- Enrollment
- 30 patients (estimated)
- Sponsors
- University of Nebraska
- Tags
- Placebo, Randomization
- Trial Type
- Supportive
- Last Update
- 2 months ago
- SparkCures ID
- 1930
- NCT Identifier
- NCT05135351
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print this trial to share with your doctor.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.